HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation

[1]  A. Bakker.  Einige Übereinstimmungen im Stoffwechsel der Carcinomzellen und Exsudatleukocyten , 1927, Klinische Wochenschrift.

[2]  W. Reith,et al.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice , 1999, Transgenic Research.

[3]  D. Weisdorf,et al.  Granulocytes utilize different energy sources for movement and phagocytosis , 1982, Inflammation.

[4]  J. Platt,et al.  Regional manifestations and control of the immune system , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  C. Lewis,et al.  Expression of HIF‐1α by human macrophages: implications for the use of macrophages in hypoxia‐regulated cancer gene therapy , 2002, The Journal of pathology.

[6]  J. M. Arbeit,et al.  Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. , 2001, Genes & development.

[7]  S. Krauss,et al.  Signaling takes a breath--new quantitative perspectives on bioenergetics and signal transduction. , 2001, Immunity.

[8]  G. Semenza,et al.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. , 2001, Trends in molecular medicine.

[9]  K. Uyeda,et al.  Regulation of Energy Metabolism in Macrophages during Hypoxia , 2001, The Journal of Biological Chemistry.

[10]  A. Hollander,et al.  Expression of hypoxia-inducible factor 1alpha by macrophages in the rheumatoid synovium: implications for targeting of therapeutic genes to the inflamed joint. , 2001, Arthritis and rheumatism.

[11]  P. Thibault,et al.  Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.

[12]  G. Semenza.  Hypoxia-Inducible Factor 1: Control of Oxygen Homeostasis in Health and Disease , 2001, Pediatric Research.

[13]  P Vaupel,et al.  Biological consequences of tumor hypoxia. , 2001, Seminars in oncology.

[14]  G. Semenza.  HIF-1 and mechanisms of hypoxia sensing. , 2001, Current opinion in cell biology.

[15]  W. Kaelin,et al.  The von Hippel-Lindau tumor suppressor gene. , 2001, Experimental cell research.

[16]  A. Giaccia,et al.  Tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy) and metastasis. , 2001, Cancer research.

[17]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1α and HIF-2α in normal human tissues, cancers, and tumor-associated macrophages , 2000 .

[18]  B. Babior.  Phagocytes and oxidative stress. , 2000, The American journal of medicine.

[19]  G. Burmester,et al.  Bioenergetics of immune functions: fundamental and therapeutic aspects. , 2000, Immunology today.

[20]  H. Dvorak,et al.  VPF/VEGF and the angiogenic response. , 2000, Seminars in perinatology.

[21]  T. Thepen,et al.  Resolution of cutaneous inflammation after local elimination of macrophages , 2000, Nature Biotechnology.

[22]  K. Korhonen.  Hyperbaric oxygen therapy in acute necrotizing infections. With a special reference to the effects on tissue gas tensions. , 2000, Annales chirurgiae et gynaecologiae.

[23]  O. Lider,et al.  Modulation of Leukocyte Behavior by an Inflamed Extracellular Matrix , 2000, Developmental immunology.

[24]  A. Harris,et al.  Macrophage responses to hypoxia: relevance to disease mechanisms , 1999, Journal of leukocyte biology.

[25]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[26]  C. Scotton,et al.  Hypoxia inhibits macrophage migration , 1999, European journal of immunology.

[27]  J. Vincent,et al.  Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. , 1999, Metabolism: clinical and experimental.

[28]  C. Wykoff,et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.

[29]  K. Rajewsky,et al.  From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. , 1999, Immunity.

[30]  D. Hanahan,et al.  Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function. , 1999, Cancer research.

[31]  Jessica Lo,et al.  HIF‐1α is required for solid tumor formation and embryonic vascularization , 1998 .

[32]  V. Nizet,et al.  Invasion of brain microvascular endothelial cells by group B streptococci , 1997 .

[33]  G. Semenza,et al.  Hypoxia-Inducible Factor 1 , 1998 .

[34]  V. Kouskoff,et al.  Organ-Specific Disease Provoked by Systemic Autoimmunity , 1996, Cell.

[35]  G. Hunninghake,et al.  Effect of hypoxia on release of IL-1 and TNF by human alveolar macrophages. , 1996, American journal of respiratory cell and molecular biology.

[36]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[37]  T. Standiford,et al.  Alterations of ambient oxygen tension modulate the expression of tumor necrosis factor and macrophage inflammatory protein-1 alpha from murine alveolar macrophages. , 1995, American journal of respiratory cell and molecular biology.

[38]  P. Mapp,et al.  Hypoxia, oxidative stress and rheumatoid arthritis. , 1995, British medical bulletin.

[39]  H. Najafipour,et al.  Comparison of synovial PO2 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints , 1995, Experimental physiology.

[40]  H. Simmen,et al.  Analysis of pH, pO2 and pCO2 in drainage fluid allows for rapid detection of infectious complications during the follow-up period after abdominal surgery , 1994, Infection.

[41]  D. Staunton,et al.  Targeted disruption of CD43 gene enhances T lymphocyte adhesion. , 1993, Journal of immunology.

[42]  R. Sawyer,et al.  The peritoneal environment during infection. The effect of monomicrobial and polymicrobial bacteria on pO2 and pH. , 1991, Annals of surgery.

[43]  L. Hurwitz.  Where is the energy , 1988 .

[44]  S. Kumar,et al.  Wound healing: the effect of macrophage and tumour derived angiogenesis factors on skin graft vascularization. , 1987, British journal of experimental pathology.

[45]  A. Ott.  Inflammation and transcutaneous measurement of oxygen pressure in dermatology. , 1987, Advances in experimental medicine and biology.

[46]  P. D. Kittlick.  Inflammation, glycolytic metabolism, and glycosaminoglycans. , 1986, Experimental pathology.

[47]  S. Yamamoto,et al.  Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. , 1985, Japanese journal of pharmacology.

[48]  T. Herlin,et al.  Energy metabolism of human neutrophils during phagocytosis. , 1982, The Journal of clinical investigation.

[49]  D. Priebat,et al.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.

[50]  D. Weisdorf,et al.  Glycogenolysis versus glucose transport in human granulocytes: differential activation in phagocytosis and chemotaxis. , 1982, Blood.

[51]  N. Kay,et al.  Effects of 2-deoxy-D-glucose on human monocyte metabolism and function. , 1980, Journal of the Reticuloendothelial Society.

[52]  L. Simchowitz,et al.  Chemotactic factor-induced generation of superoxide radicals by human neutrophils: evidence for the role of sodium. , 1979, Journal of immunology.

[53]  D. Roos,et al.  A metabolic comparison between human blood monocytes and neutrophils. , 1979, Advances in experimental medicine and biology.

[54]  L. Simchowitz,et al.  Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. , 1979, Arthritis and rheumatism.

[55]  D. Roos,et al.  Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. , 1978, The Journal of clinical investigation.

[56]  P. Ward,et al.  Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. , 1977, Journal of immunology.

[57]  L. Boxer,et al.  The effect of 2‐deoxyglucose on guinea pig polymorphonuclear leukocyte phagocytosis , 1977, Journal of cellular physiology.

[58]  J. Michl,et al.  2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages II. Dissociation of the inhibitory effects of 2-deoxyglucose on phagocytosis and ATP generation , 1976, The Journal of experimental medicine.

[59]  I. Silver.  Measurement of pH and ionic composition of pericellular sites. , 1975, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[60]  A. Raick.  Ultrastructural, histological, and biochemical alterations produced by 12-O-tetradecanoyl-phorbol-13-acetate on mouse epidermis and their relevance to skin tumor promotion. , 1973, Cancer research.

[61]  G. Manns.  [Determination of glycolysis metabolites in inflamed and non-inflamed paw tissue of rats]. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.

[62]  H. Koch,et al.  [The energy situation in the course of acute experimental inflammation]. , 1967, Medicina et pharmacologia experimentalis. International journal of experimental medicine.

[63]  D. N. Kellett.  2‐Deoxyglucose and inflammation , 1966, The Journal of pharmacy and pharmacology.

[64]  M L KARNOVSKY,et al.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. , 1959, The Journal of biological chemistry.

[65]  W. Kempner.  THE NATURE OF LEUKEMIC BLOOD CELLS AS DETERMINED BY THEIR METABOLISM. , 1939, The Journal of clinical investigation.

[66]  P. Levene,et al.  ON THE ACTION OF LEUCOCYTES ON GLUCOSE SECOND COMMUNICATION , 1912 .

[67]  P. Levene,et al.  THE ACTION OF LEUCOCYTES ON GLUCOSE , 1912 .